Daniel Seidl

发表

Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology

D. Rades, H. Lehnert, R. Hass, 2013, PloS one.

Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck.

B. Wollenberg, D. Rades, S. Schild, 2016, Anticancer research.

A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers.

B. Wollenberg, D. Rades, S. Schild, 2018, Anticancer research.

Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.

S. Yildiz, C. Schwentner, Ye Lei, 2019, Journal of endourology.

Interaction of tumor cells with the microenvironment

Hendrik Lehnert, Ralf Hass, H. Lehnert, 2011, Cell Communication and Signaling.

Correction: Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology

D. Rades, H. Lehnert, R. Hass, 2013, PLoS ONE.

Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks.

B. Wollenberg, D. Rades, S. Schild, 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?

B. Wollenberg, D. Rades, S. Schild, 2016, Oral oncology.

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort

C. Lutz, V. Grünwald, G. Niegisch, 2023, European urology open science.

The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.

B. Wollenberg, D. Rades, S. Schild, 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?

B. Wollenberg, D. Rades, S. Schild, 2016, Oral oncology.

Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.

D. Rades, S. Schild, P. Strojan, 2016, Anticancer research.

Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers

B. Wollenberg, D. Rades, S. Schild, 2017, European Archives of Oto-Rhino-Laryngology.

Prognostic Factors in Patients Irradiated for Recurrent Head-and-Neck Cancer.

B. Wollenberg, D. Rades, S. Schild, 2016, Anticancer research.

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers

D. Rades, S. Schild, P. Strojan, 2016, BMC Cancer.

The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.

B. Wollenberg, D. Rades, S. Schild, 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.